Aetiology And Outcome Of Children With Thrombocytosis Admitted to Assiut University Children Hospital

Launched by ASSIUT UNIVERSITY · Mar 25, 2024

Keywords

ClinConnect Summary

This clinical trial is looking into a condition called thrombocytosis, which means having a higher than normal number of platelets in the blood, in children who are admitted to Assiut University Children's Hospital. The main goal of the study is to find out what causes thrombocytosis in kids and to understand how it affects their health and recovery. The trial is open to children aged from 1 month to 18 years who are diagnosed with this condition, but it will not include newborns or children with certain blood cancers or disorders.

If your child is eligible and participates in this study, they will receive careful evaluation and monitoring while in the hospital. The findings from this trial could help doctors better understand thrombocytosis in children and improve treatment options in the future. It's important to note that the trial is not yet recruiting participants, so there will be more information available when it begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all patients from age 1 month to 18 years old , who were admitted to Assiut University Children's Hospital with thrombocytosis
• Exclusion Criteria:
• • 1-Neonates ,Children with malignancy , 2_Children with polycythemia vera